High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

<h4>Background</h4>Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miguel de Mulder, Gonzalo Yebra, Adriana Navas, María Isabel de José, María Dolores Gurbindo, María Isabel González-Tomé, María José Mellado, Jesús Saavedra-Lozano, María Ángeles Muñoz-Fernández, Santiago Jiménez de Ory, José Tomás Ramos, Africa Holguín, Madrid Cohort of HIV-Infected Children
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f5bb0d8e6b9b4a2ea8f04fd82a3aed53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f5bb0d8e6b9b4a2ea8f04fd82a3aed53
record_format dspace
spelling oai:doaj.org-article:f5bb0d8e6b9b4a2ea8f04fd82a3aed532021-11-18T08:04:46ZHigh drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.1932-620310.1371/journal.pone.0052155https://doaj.org/article/f5bb0d8e6b9b4a2ea8f04fd82a3aed532012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284913/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children.<h4>Methods</h4>Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid.<h4>Results</h4>One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had ≤ 200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%).<h4>Conclusion</h4>Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units.Miguel de MulderGonzalo YebraAdriana NavasMaría Isabel de JoséMaría Dolores GurbindoMaría Isabel González-ToméMaría José MelladoJesús Saavedra-LozanoMaría Ángeles Muñoz-FernándezSantiago Jiménez de OryJosé Tomás RamosAfrica HolguínMadrid Cohort of HIV-Infected ChildrenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e52155 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Miguel de Mulder
Gonzalo Yebra
Adriana Navas
María Isabel de José
María Dolores Gurbindo
María Isabel González-Tomé
María José Mellado
Jesús Saavedra-Lozano
María Ángeles Muñoz-Fernández
Santiago Jiménez de Ory
José Tomás Ramos
Africa Holguín
Madrid Cohort of HIV-Infected Children
High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
description <h4>Background</h4>Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children.<h4>Methods</h4>Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid.<h4>Results</h4>One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had ≤ 200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%).<h4>Conclusion</h4>Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units.
format article
author Miguel de Mulder
Gonzalo Yebra
Adriana Navas
María Isabel de José
María Dolores Gurbindo
María Isabel González-Tomé
María José Mellado
Jesús Saavedra-Lozano
María Ángeles Muñoz-Fernández
Santiago Jiménez de Ory
José Tomás Ramos
Africa Holguín
Madrid Cohort of HIV-Infected Children
author_facet Miguel de Mulder
Gonzalo Yebra
Adriana Navas
María Isabel de José
María Dolores Gurbindo
María Isabel González-Tomé
María José Mellado
Jesús Saavedra-Lozano
María Ángeles Muñoz-Fernández
Santiago Jiménez de Ory
José Tomás Ramos
Africa Holguín
Madrid Cohort of HIV-Infected Children
author_sort Miguel de Mulder
title High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
title_short High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
title_full High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
title_fullStr High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
title_full_unstemmed High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
title_sort high drug resistance prevalence among vertically hiv-infected patients transferred from pediatric care to adult units in spain.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/f5bb0d8e6b9b4a2ea8f04fd82a3aed53
work_keys_str_mv AT migueldemulder highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT gonzaloyebra highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT adriananavas highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT mariaisabeldejose highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT mariadoloresgurbindo highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT mariaisabelgonzaleztome highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT mariajosemellado highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT jesussaavedralozano highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT mariaangelesmunozfernandez highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT santiagojimenezdeory highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT josetomasramos highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT africaholguin highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT madridcohortofhivinfectedchildren highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
_version_ 1718422265966624768